News

We're delighted to announce the election of Professor Schiavo (Professor of Cellular Neuroscience, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology) to Academia Europaea.

Results of the MIROCALS (Modifying Immune Responses and Outcomes in ALS) clinical trial are published today in The Lancet.

The Charcot-Marie-Tooth Association (CMTA) has announced a $210,000 investment to advance gene discovery and improve diagnostic success for people with Charcot-Marie-Tooth disease

The partnership supports a Global Project to Advance Alzheimer’s Disease Research in North Africa, with an international team aiming to develop better understanding of Alzheimer’s disease and dementia

We're delighted to announce that Dr Viorica Chelban and Dr Christian Lambert (UCL Queen Square Institute of Neurology) have been awarded grants through The Galen and Hilary Weston Foundation

The Neurogenetics Lab, UCL Queen Square Institute of Neurology, recently welcomed families from around the world for a dedicated Patient Engagement Day focused on NARS1-related neurodevelopmental diso

Professor Robert Pitceathly has been appointed as the next Head of Research Department of Neuromuscular Diseases at the UCL Queen Square Institute of Neurology.

For World Rare Disease Day 2025, the Neurogenetics Lab at UCL Queen Square Institute of Neurology is celebrating the invaluable contributions of our international collaborators, whose dedication is driving ground-breaking advancements in rare disease research across the globe.

A landmark study, involving UCL Queen Square Institute of Neurology researchers, has found 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.

Congratulations to Professor Mary Reilly, a globally renowned and award-winning clinical neurologist, who has been awarded an honorary MBE for her services to medicine.

During Half Term, students from the Neurogenetics Lab at UCL Queen Square Institute of Neurology collaborated with Little House of Science to host an engaging day of neuroscience and genetics for 96 children aged 4-13.

The genetic cause for the most common type of hearing loss in children with Down syndrome has been identified in mice by researchers at UCL Queen Square Institute of Neurology, the Francis Crick Institute and MRC Harwell Institute.

Novel molecule, KL1333 has shown promising results with reduced fatigue and improved functional strength for those with primary mitochondrial disease, in results from a trial led by researchers at UCL Queen Square Institute of Neurology and pharmaceutical company Abliva.

Researchers from the UCL Queen Square Institute of Neurology investigated the DNA of families affected by rare paediatric neurological diseases, identifying unique and distinct variants specific to each country in the region.

We're delighted to announce that Alya Masoud Abdelhafid (PhD Student in UCL Queen Square Institute of Neurology) has been selected as a finalist for WiNUK's Rising Star (Postgraduate) Award at the upcoming Women in Neuroscience UK (WiNUK) Award Ceremony.